Afrezza (Mannkind) investors - the "fault" is yours

[anonymous]

If one did appropriate research they never would have invested in Mannkind. The prescribers didn't want it. While they saw it as novel they were aware of its potential risk (lung function) and were concerned of issues related to variable absorption based on respiratory health (which varies in event of virus). That was enough for them to prevent prescribing the product. Any objective person in their shoes would do the same thing. And with that let the bitter self centered investors reply...

 

[anonymous]

If one did appropriate research they never would have invested in Mannkind. The prescribers didn't want it. While they saw it as novel they were aware of its potential risk (lung function) and were concerned of issues related to variable absorption based on respiratory health (which varies in event of virus). That was enough for them to prevent prescribing the product. Any objective person in their shoes would do the same thing. And with that let the bitter self centered investors reply...

This is the mindset that has caused the current predicament; a huge layoff, due to the diabetes franchise crashing and burning. You had a drug that could have made a huge impact on your bottom line for years to come, but instead, from on high down to the rep level, there was no commitment. No plan. No nothing. Just excuses. The potential risks that keep coming up on this board are no worse...in fact, they are far more benign than many s/e's seen with oral diabetes meds succeeding right now. Excuse after excuse. Now a RIF is in the pipe, in which Sanofi US will take the bulk, and sales the bulk of that. or at least it looks that way. You had this product, a disruption to the status quo, and you think it's going to catch on in a years time? Amateurs. Hell yes I'm an investor, and working in the medical field. The difference is that I really want what is best for the patient. The drugs that Sanofi offers, the ones that are flailing right now even with the 24/7 commercials (how much is that costing Sanofi?) are not it.

 

[anonymous]

"concerned of issues related to variable absorption based on respiratory health (which varies in event of virus)."

This is reason for many not to write.

 

[anonymous]

You are kicking a dead horse. Who cares?

 

[anonymous]

This is the mindset that has caused the current predicament; a huge layoff, due to the diabetes franchise crashing and burning. You had a drug that could have made a huge impact on your bottom line for years to come, but instead, from on high down to the rep level, there was no commitment. No plan. No nothing. Just excuses. The potential risks that keep coming up on this board are no worse...in fact, they are far more benign than many s/e's seen with oral diabetes meds succeeding right now. Excuse after excuse. Now a RIF is in the pipe, in which Sanofi US will take the bulk, and sales the bulk of that. or at least it looks that way. You had this product, a disruption to the status quo, and you think it's going to catch on in a years time? Amateurs. Hell yes I'm an investor, and working in the medical field. The difference is that I really want what is best for the patient. The drugs that Sanofi offers, the ones that are flailing right now even with the 24/7 commercials (how much is that costing Sanofi?) are not it.

Try this Mr investor troll. Speak to two docs and ask their opinion of the drug.

You'll see its shit. Mannkind was worth a dollar a share. Speculators pumped the stock based on expectations not value.

Then they borrowed hundreds of millions. They went so far as to float shares in the Israeli stock exchange. Back on the
NASDAQ it was the most heavily shorted stock in history.

I was out there in the trenches fighting , selling, begging. I was selling for my life. My abl and his boss and Paul Hawthorne and Jerry balzer cracked the whip. All to no avail. Your drug was shit, hard to dose, had no formularies, needed pretesting. It was crap. Trust me. I am a top rep with a track record is success.

2 months in I saw it was a lost cause.

Fuck you, fuck mannkind, fuck the speculators, fuck Sanofi. We were presented with a dead canary and even zig ziglar himself couldn't sell this shit.

I hope you lost thousands of dollars. That's what you get when you gamble.

Now get lost.

 

[anonymous]

Try this Mr investor troll. Speak to two docs and ask their opinion of the drug.

You'll see its shit. Mannkind was worth a dollar a share. Speculators pumped the stock based on expectations not value.

Then they borrowed hundreds of millions. They went so far as to float shares in the Israeli stock exchange. Back on the
NASDAQ it was the most heavily shorted stock in history.

I was out there in the trenches fighting , selling, begging. I was selling for my life. My abl and his boss and Paul Hawthorne and Jerry balzer cracked the whip. All to no avail. Your drug was shit, hard to dose, had no formularies, needed pretesting. It was crap. Trust me. I am a top rep with a track record is success.

2 months in I saw it was a lost cause.

Fuck you, fuck mannkind, fuck the speculators, fuck Sanofi. We were presented with a dead canary and even zig ziglar himself couldn't sell this shit.

I hope you lost thousands of dollars. That's what you get when you gamble.

Now get lost.

This loser has a job and will continue to do so, same may not be the case for you. Again, childish attitude is why SNY diabetes franchise is failing and many reps are getting axed soon. I can afford to lose thousands and still sit back for a week and binge on Netflix. Be that as it may MNKD is still a viable company, so lime many other stocks, you hold and move on. You need to brush off that resume and pound the pavement to keep that roof over your head. I will look here in a month and see who's still trolling.

 

[anonymous]

This is the mindset that has caused the current predicament; a huge layoff, due to the diabetes franchise crashing and burning. You had a drug that could have made a huge impact on your bottom line for years to come, but instead, from on high down to the rep level, there was no commitment. No plan. No nothing. Just excuses. The potential risks that keep coming up on this board are no worse...in fact, they are far more benign than many s/e's seen with oral diabetes meds succeeding right now. Excuse after excuse. Now a RIF is in the pipe, in which Sanofi US will take the bulk, and sales the bulk of that. or at least it looks that way. You had this product, a disruption to the status quo, and you think it's going to catch on in a years time? Amateurs. Hell yes I'm an investor, and working in the medical field. The difference is that I really want what is best for the patient. The drugs that Sanofi offers, the ones that are flailing right now even with the 24/7 commercials (how much is that costing Sanofi?) are not it.